| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2023 | Aug 29, 2023 | Cue Biopharma, Inc. | President | Buy | 83.8 | +4,000 | 3.04% | ✗ | $11K |
| Mar 31, 2022 | Apr 4, 2022 | Cue Biopharma, Inc. | President | Sell | 26.3 | -7,068 | -6.38% | ✗ | $34.5K |
| Nov 15, 2021 | Nov 17, 2021 | Cue Biopharma, Inc. | President | Sell | 28.8 | -8,000 | -7.84% | ✓ | $144.4K |
| Nov 11, 2021 | Nov 15, 2021 | Cue Biopharma, Inc. | President | Sell | 17.5 | -20,000 | -17.54% | ✓ | $301.4K |
| Oct 3, 2021 | Oct 8, 2021 | Cue Biopharma, Inc. | President | Sell | 22.5 | -14,134 | -13.07% | ✗ | $183.3K |
| Sep 23, 2021 | Sep 27, 2021 | Cue Biopharma, Inc. | President | Sell | 12.5 | -20,000 | -21.09% | ✓ | $304.6K |
| Oct 3, 2020 | Oct 6, 2020 | Cue Biopharma, Inc. | President | Sell | 22.5 | -9,800 | -14.43% | ✗ | $159.7K |
| Aug 5, 2020 | Aug 7, 2020 | Cue Biopharma, Inc. | President | Sell | 45.0 | -800 | -2.26% | ✓ | $16K |
| Aug 3, 2020 | Aug 5, 2020 | Cue Biopharma, Inc. | President | Sell | 28.8 | -6,200 | -8.23% | ✓ | $124.1K |
| Nov 1, 2019 | Nov 4, 2019 | Cue Biopharma, Inc. | President | Sell | 22.5 | -12,087 | -34.21% | ✗ | $104.3K |
| Dec 21, 2018 | Dec 26, 2018 | Cue Biopharma, Inc. | Chief Scientific Officer | Buy | 90.0 | +2,000 | 100.00% | ✗ | $8.7K |